Gene therapy and respiratory neuroplasticity

Area of Science:

• Neuroscience
• Respiratory Medicine
• Gene Therapy

Background:

• Breathing relies on complex motor control of respiratory muscles by the brainstem and spinal cord.
• Dysfunction in respiratory motor control leads to significant morbidity and mortality.
• Gene therapy offers novel strategies for understanding and treating respiratory disorders.

Purpose of the Study:

• To review current evidence on gene therapy for respiratory disorders.
• To focus on interventions targeting respiratory motor control and neuroplasticity.
• To highlight the role of adeno-associated viruses (AAV) in these interventions.

Main Methods:

• Review of recent studies on gene therapy for respiratory motor control.
• Focus on adeno-associated virus (AAV) vector systems.
• Examination of AAV's ability to target respiratory motoneurons and muscle fibers.

Main Results:

• Adeno-associated viruses (AAV) are versatile vectors for gene delivery in the respiratory system.
• AAV can effectively transduce respiratory motoneurons and muscle fibers.
• Gene therapy with AAV demonstrates promising therapeutic effects on respiratory function.

Conclusions:

• Gene therapy, especially using AAV, is a powerful tool for addressing respiratory motor control deficits.
• This approach holds potential for promoting neuroplasticity and regeneration in respiratory disorders.
• Further research is warranted to fully realize the therapeutic benefits of gene therapy in respiratory medicine.